Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.
Show more...
FAQ
Ascendis Pharma A/S 今天的股價是多少?▼
A1SN34.SA 目前價格為 R$76.24 BRL,過去 24 小時上漲了 +1.5%。在圖表上更密切關注 Ascendis Pharma A/S 股價表現。
Ascendis Pharma A/S 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Ascendis Pharma A/S 的股票以代號 A1SN34.SA 進行交易。
Ascendis Pharma A/S 去年的營收是多少?▼
Ascendis Pharma A/S 去年的營收為 4.53BBRL。
Ascendis Pharma A/S 去年的淨利是多少?▼
A1SN34.SA 去年的淨收益為 -4.63BBRL。
Ascendis Pharma A/S 有多少名員工?▼
截至 February 02, 2026,公司共有 639 名員工。
Ascendis Pharma A/S 位於哪個產業?▼
Ascendis Pharma A/S從事於Healthcare產業。
Ascendis Pharma A/S 何時完成拆股?▼
Ascendis Pharma A/S 最近沒有進行任何拆股。
Ascendis Pharma A/S 的總部在哪裡?▼
Ascendis Pharma A/S 的總部位於 Denmark 的 Hellerup。